FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

The Marriott Inn and Conference Center, University of Maryland University College (UMUC) 

Potomac Ballroom, 3501 University Blvd. East, Hyattsville, Maryland 

 

 

September 11, 2014 

MEETING ROSTER 

 

 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Karen Abraham-Burrell, PharmD  
Division of Advisory Committee and Consultant Management 
Office of Executive Programs 
Center for Drug Evaluation and Research 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
David W. Cooke, MD 
Associate Professor of Pediatrics 
Clinical Director, Division of Pediatric 
Endocrinology 
Director, Pediatric Endocrine Fellowship 
Training Program  
Johns Hopkins University School of Medicine 
Baltimore, Maryland 
 
Diana Hallare, MPH  
(Consumer Representative) 
Visalia, California 
 
 

William R. Hiatt, MD, FACP 
Professor of Medicine  
Division of Cardiology 
University of Colorado School of Medicine  
President, Colorado Prevention Center  (CPC) 
Clinical Research 
Aurora, Colorado  
 

Charles A. Stanley, MD 
Professor of Pediatrics 
Perelman School of Medicine University of 
Pennsylvania  
Division of Endocrinology & Diabetes 
Children’s Hospital of Philadelphia 
Philadelphia, Pennsylvania 
 

TEMPORARY MEMBERS (Voting)  
 
Daniel Budnitz, MD, MPH 
Medical Officer 
Division of Healthcare Quality Promotion 
Centers for Disease Control and Prevention 
(CDC) 
Atlanta, Georgia 
 
 
 

Page 1 of 3 

Kenneth Burman, MD 
(Acting Chairperson) 
Chief, Endocrine Section 
Washington Hospital Center 
Washington, District of Columbia  
 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

September 11, 2014 

 

 

MEETING ROSTER (cont.) 

 

 

TEMPORARY MEMBERS (Voting) (cont.) 

Brendan Everett, MD, MPH 
Director, General Cardiology Inpatient Service, 
Brigham and Women’s Hospital 
Assistant Professor of Medicine, Harvard 
Medical School 
Boston, Massachusetts 
 
Barbara C. Hansen, PhD 
Department of Internal Medicine and Pediatrics 
Morsani College of Medicine 
University of South Florida 
Tampa, Florida   
 

Susan R. Heckbert, MD, PhD 
Professor 
Department of Epidemiology 
University of Washington 
Seattle, Washington 
 
 

David Kelsen, MD 
Attending Physician 
Gastrointestinal Oncology Service 
Memorial Sloan Kettering Cancer Center 
New York, New York 
 
Corby K. Martin, PhD 
Associate Professor; Director, Ingestive 
Behavior Laboratory 
Pennington Biomedical Research Center - 
Louisiana State University System  
Baton Rouge, Louisiana 
 
 

Lynn McAfee 
(Patient Representative) 
Director, Medical Advocacy 
Council on Size & Weight Discrimination 
North Port, Florida 

Martha Nason, PhD 
Mathematical Statistician 
Biostatistics Research Branch, Division of 
Clinical Research 
National Institute of Allergy and Infectious 
Diseases, National Institutes of Health (NIH) 
Bethesda, Maryland 
 
Christy Boling Turer, MD, MHS 
Assistant Professor of Pediatrics and Internal 
Medicine 
Divisions of General Pediatrics and General 
Internal Medicine 
UTSW, Children’s Medical Center Dallas, and 
Parkland Health and Hospital System 
Dallas, Texas 
 
Susan Z. Yanovski, MD 
Co-Director, Office of Obesity Research 
National Institute of Diabetes and Digestive and 
Kidney Diseases, NIH 
Bethesda, Maryland 
 
 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

September 11, 2014 

MEETING ROSTER (cont.) 

 

 

 

 

 

INDUSTRY REPRESENTATIVE TO THE COMMITTEE (Non-Voting) 
 
Rob Scott, MD 
(Acting Industry Representative) 
Vice President, Global Clinical Development 
Cardiovascular Therapeutic Area Head 
Amgen Inc. 
One Amgen Center Drive 
Thousand Oaks, California  
 
FDA PARTICIPANTS (Non-Voting) 
 
Mary Parks, MD 
Deputy Director 
Office of Drug Evaluation II (ODE II) 
Office of New Drugs (OND), CDER, FDA 
 
Jean-Marc Guettier, MD, CM 
Director  
Division of Metabolism and Endocrinology 
Products (DMEP), ODE II, OND, CDER, FDA 
 

 
 
Julie Golden, MD  
Medical Officer 
DMEP, ODE II, OND, CDER, FDA  
 

Solomon Iyasu, MD, MPH  
Director, Office of Pharmacovigilance and 
Epidemiology (OPE) 
Office of Surveillance and Epidemiology (OSE) 
CDER, FDA 
 
 

James P. Smith, MD, MS  
Clinical Team Leader 
DMEP, ODE II, OND, CDER, FDA 
 
 
 
 
 

 

Page 3 of 3 

